脳神経外科の世界市場

脳神経外科の世界市場は2030年までに51億米ドルに達する見込み

2024年に43億米ドルと推定される脳神経外科の世界市場は、分析期間2024-2030年にCAGR 3.1％で成長し、2030年には51億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである神経インターベンショナルデバイスは、CAGR 4.0％を記録し、分析期間終了までに14億米ドルに達すると予測されます。神経内視鏡セグメントの成長率は、分析期間中CAGR 3.7%と推定されます。

米国市場は12億米ドル、中国はCAGR6.0％で成長予測

米国の脳神経外科市場は2024年に12億米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを6.0%として、2030年までに10億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.2%と2.4%と予測されています。欧州では、ドイツがCAGR 1.8%で成長すると予測されています。

世界の脳神経外科市場- 主要動向と促進要因のまとめ

なぜ脳神経外科は世界の外科診療の中で精密さ中心の分野に進化しているのか？

脳神経外科は、脳、脊椎、末梢神経に影響を及ぼす疾患の外科治療に関する医療専門分野であるが、精密医療、高度な画像診断、低侵襲技術によって大きな変革が起こりつつあります。かつて脳神経外科は、生命を脅かす緊急手術やリスクの高い腫瘍切除術を主な対象としていたが、現在では脳深部刺激療法、脊髄減圧術、てんかん手術、脳卒中や動脈瘤に対する血管内治療など、幅広い選択的・修復的手術を包含しています。

神経疾患、外傷、脊椎疾患、神経腫瘍症例の世界の増加により、先進経済諸国と新興経済諸国の両方で神経外科サービスへの需要が高まっています。人口の高齢化が進み、退行性脊髄疾患、脳卒中、脳腫瘍の負担が増加する中、脳神経外科は総合的な神経学的ケアに不可欠なものとなりつつあります。さらに、ロボット工学、ナビゲーションシステム、術中モニタリングの導入により、複雑な手術がより安全で、再現性が高く、侵襲性が低くなり、修復と機能的な結果における脳神経外科の役割が拡大しています。

ロボット工学、画像技術、データ統合は、脳神経外科手術の精度と安全性をどのように高めているのか？

技術の進歩は、脳神経外科の運用状況を再定義しています。術中MRI、神経ナビゲーション、ロボット支援システムにより、腫瘍切除、電極配置、脊髄器具の装着においてミリメートルレベルの精度が可能になりつつあります。これらの技術により、外科医は3D再構成を用いた手術計画を立て、さまざまな手術経路をシミュレーションし、リアルタイムの解剖学的変化に基づいて術中に適応することができます。画像誘導手術（IGS）は、低侵襲開頭術や内視鏡下経鼻頭蓋底手術でますます使用されるようになっており、副次的損傷を減らし、神経学的転帰を改善しています。

人工知能（AI）と機械学習は、術前計画、術中意思決定支援、術後リスク評価に応用されています。AIによるセグメンテーション・ツールは重要な脳領域の特定に役立ち、予測モデルは手術合併症や回復時期の予測を支援します。さらに、電子カルテ、手術ビデオ分析、神経生理学的データの統合は、集学的治療と長期転帰追跡を強化しています。これらの技術革新は、手技の精度を高めるだけでなく、遠隔学習や拡張現実トレーニングプラットフォームを通じて、脳神経外科の専門知識を民主化しています。

脳神経外科サービスの世界需要を形成している患者セグメントとヘルスケアシステムとは？

脳神経外科は、脳腫瘍、外傷性脳損傷、脳卒中関連出血、水頭症、てんかん、脊椎椎間板疾患、キアリ奇形や二分脊椎などの先天性奇形など、幅広い患者集団に対応しています。特に、変性脊椎手術、脳血管手術、腫瘍切除術などでは、脳神経外科患者に占める高齢者の割合が増加しています。小児脳神経外科も、先天異常や神経発達障害に対応する重要なサブスペシャリティであることに変わりはないです。

北米が脳神経外科の世界市場をリードしているのは、高度な病院インフラ、手術件数の多さ、手術器具の継続的な技術革新によるものです。欧州は、強力な公的医療資金と画像誘導およびロボット神経外科システムの普及により、僅差でこれに続きます。アジア太平洋は、特にインド、中国、韓国、日本で急速に拡大しており、患者数の増加、脳神経外科トレーニングプログラムの改善、医療保険適用率の上昇がその原動力となっています。ラテンアメリカ、中東・アフリカの新興市場では、医療ツーリズム、官民パートナーシップ、外科ミッションプログラムを通じて、脳神経外科医療への投資が行われています。

脳神経外科市場の長期的成長と多職種統合の原動力は？

脳神経外科市場の成長の原動力は、神経・脊髄疾患の世界の負担の増大、手術技術の進歩、低侵襲・機能温存手術への動きです。神経外科医、神経科医、放射線科医、麻酔科医、リハビリテーション専門医の連携が進み、患者の転帰を向上させ回復を早める包括的な連続治療が実現しつつあります。

今後の成長は、機能的な脳神経外科（運動障害、精神疾患、疼痛など）、ブレイン・コンピュータ・インターフェイス、植え込み型神経刺激装置の動向によって形作られるであろう。ロボットによる自動化、クラウドベースの手術データプラットフォーム、遠隔脳神経外科は、手術の範囲とオペレーションの効率を高めると思われます。脳神経外科は精密性、個別化、多領域性へと進化を続けており、世界の現代医療においてダイナミックで不可欠な柱であり続けるでしょう。

セグメント

製品タイプ（神経インターベンショナルデバイス、神経内視鏡、神経外科用ドリル、放射線手術システム、硬膜代替物、その他製品タイプ）、適応症（脳腫瘍適応症、脊椎・頭蓋底腫瘍適応症、外傷性脳損傷適応症、頭蓋顔面外傷適応症、その他適応症）、最終用途（病院・専門クリニック最終用途、外来手術センター最終用途、その他最終用途）

調査対象企業の例（合計 36注目の企業）

• Abbott Laboratories
• Adeor Medical AG
• Aleva Neurotherapeutics
• B. Braun Melsungen AG
• Boston Scientific Corporation
• Brainlab AG
• Elekta AB
• Integra LifeSciences Holdings Corp.
• Johnson & Johnson（DePuy Synthes）
• Karl Storz SE & Co. KG
• LivaNova PLC
• Machida Endoscope Co., Ltd.
• Medtronic plc
• MicroVention Inc.（Terumo Group）
• NuVasive, Inc.
• Penumbra, Inc.
• Smith & Nephew plc
• Stryker Corporation
• Synaptive Medical Inc.
• Zimmer Biomet Holdings, Inc.

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Neurosurgery Market to Reach US$5.1 Billion by 2030

The global market for Neurosurgery estimated at US$4.3 Billion in the year 2024, is expected to reach US$5.1 Billion by 2030, growing at a CAGR of 3.1% over the analysis period 2024-2030. Neuro Interventional Devices, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Neuroendoscopes segment is estimated at 3.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 6.0% CAGR

The Neurosurgery market in the U.S. is estimated at US$1.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.0 Billion by the year 2030 trailing a CAGR of 6.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.2% and 2.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Global Neurosurgery Market - Key Trends & Drivers Summarized

Why Is Neurosurgery Evolving into a Precision-Centric Discipline Within Global Surgical Practice?

Neurosurgery, the medical specialty concerned with the surgical treatment of disorders affecting the brain, spine, and peripheral nerves, is undergoing a major transformation fueled by precision medicine, advanced imaging, and minimally invasive techniques. Once associated primarily with life-threatening emergencies or high-risk tumor resections, neurosurgery now encompasses a wide spectrum of elective and restorative procedures, including deep brain stimulation, spinal decompression, epilepsy surgery, and endovascular interventions for stroke and aneurysms.

The global rise in neurological diseases, traumatic injuries, spinal disorders, and neuro-oncological cases has increased the demand for neurosurgical services across both developed and developing economies. With populations aging and the burden of degenerative spinal disease, stroke, and brain tumors increasing, neurosurgery is becoming an essential part of integrated neurological care. Moreover, the incorporation of robotics, navigation systems, and intraoperative monitoring is making complex surgeries safer, more reproducible, and less invasive, expanding the role of neurosurgery in restorative and functional outcomes.

How Are Robotics, Imaging Technologies, and Data Integration Enhancing Neurosurgical Precision and Safety?

Technological advances are redefining the operational landscape of neurosurgery. Intraoperative MRI, neuronavigation, and robotic-assisted systems are enabling millimeter-level accuracy in tumor resections, electrode placement, and spinal instrumentation. These technologies allow surgeons to plan procedures with 3D reconstructions, simulate different surgical paths, and adapt intraoperatively based on real-time anatomical shifts. Image-guided surgery (IGS) is increasingly used in minimally invasive craniotomies and endoscopic transnasal skull base procedures, reducing collateral damage and improving neurological outcomes.

Artificial intelligence (AI) and machine learning are being applied to preoperative planning, intraoperative decision support, and postoperative risk assessment. AI-driven segmentation tools help identify critical brain regions, while predictive models assist in forecasting surgical complications or recovery timelines. Additionally, the integration of electronic health records, surgical video analysis, and neurophysiological data is enhancing multidisciplinary care and long-term outcome tracking. These innovations are not only elevating procedural accuracy but also democratizing neurosurgical expertise through remote learning and augmented reality training platforms.

Which Patient Segments and Healthcare Systems Are Shaping Global Demand for Neurosurgical Services?

Neurosurgery caters to a broad spectrum of patient populations, including individuals with brain tumors, traumatic brain injuries, stroke-related hemorrhages, hydrocephalus, epilepsy, spinal disc disease, and congenital malformations such as Chiari malformations or spina bifida. The elderly account for a growing proportion of neurosurgical patients, particularly for degenerative spine surgeries, cerebrovascular procedures, and tumor resections. Pediatric neurosurgery also remains a vital sub-specialty, addressing congenital anomalies and neurodevelopmental disorders.

North America leads the global neurosurgery market due to advanced hospital infrastructure, high surgical volumes, and continuous innovation in surgical devices. Europe follows closely, with strong public health funding and widespread adoption of image-guided and robotic neurosurgical systems. Asia-Pacific is rapidly expanding, particularly in India, China, South Korea, and Japan, driven by increasing patient volumes, improved neurosurgical training programs, and rising health insurance coverage. Emerging markets in Latin America, the Middle East, and Africa are investing in neurosurgical capacity through medical tourism, public-private partnerships, and surgical mission programs.

What Is Driving Long-Term Growth and Multidisciplinary Integration in the Neurosurgery Market?

The growth in the neurosurgery market is driven by the escalating global burden of neurological and spinal disorders, advancements in surgical technology, and the movement toward minimally invasive and function-preserving procedures. Increasing collaboration between neurosurgeons, neurologists, radiologists, anesthesiologists, and rehabilitation specialists is creating a holistic continuum of care that enhances patient outcomes and accelerates recovery.

Future growth will be shaped by trends in functional neurosurgery (e.g., for movement disorders, psychiatric conditions, and pain), brain-computer interfaces, and implantable neurostimulators. Robotic automation, cloud-based surgical data platforms, and tele-neurosurgery will enhance surgical reach and operational efficiency. As neurosurgery continues to evolve toward precision, personalization, and multidisciplinarity, it is poised to remain a dynamic and indispensable pillar of modern medical intervention worldwide.

SCOPE OF STUDY:

The report analyzes the Neurosurgery market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes, Other Product Types); Indication (Brain Cancer Indication, Spine & Skull Base Tumors Indication, Traumatic Brain Injuries Indication, Craniofacial Trauma Indication, Other Indications); End-Use (Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• Abbott Laboratories
• Adeor Medical AG
• Aleva Neurotherapeutics
• B. Braun Melsungen AG
• Boston Scientific Corporation
• Brainlab AG
• Elekta AB
• Integra LifeSciences Holdings Corp.
• Johnson & Johnson (DePuy Synthes)
• Karl Storz SE & Co. KG
• LivaNova PLC
• Machida Endoscope Co., Ltd.
• Medtronic plc
• MicroVention Inc. (Terumo Group)
• NuVasive, Inc.
• Penumbra, Inc.
• Smith & Nephew plc
• Stryker Corporation
• Synaptive Medical Inc.
• Zimmer Biomet Holdings, Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Neurosurgery - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Burden of Neurological Disorders Spurs Growth in Neurosurgical Procedures
  • Advances in Intraoperative Navigation Systems Strengthen Precision and Surgical Confidence
  • Increased Adoption of Robot-Assisted Neurosurgery Drives Efficiency and Patient Outcomes
  • Expansion of Neuroendoscopic Techniques Propels Minimally Invasive Surgical Interventions
  • Growing Utilization of 3D Imaging and AR/VR Platforms Enhances Pre-Surgical Planning Accuracy
  • Rise in Traumatic Brain Injuries and Spinal Disorders Expands Addressable Patient Pool
  • Integration of AI in Neurosurgical Workflows Throws the Spotlight on Predictive Analytics
  • Global Expansion of Neurosurgery Centers in Emerging Economies Drives Market Penetration
  • Improved Training Through Simulators and Virtual Labs Enhances Surgeon Proficiency and Case Volume
  • Development of Cost-Effective Neurosurgical Tools Supports Accessibility in Resource-Constrained Settings
  • Regulatory Approvals of Navigation-Assisted Implants Accelerate Technology Adoption
  • Growth in Awake Craniotomy Procedures Enhances Functional Outcomes and Recovery Metrics
  • Increased Clinical Focus on Pediatric Neurosurgery Supports Early Intervention Protocols
  • Postoperative Recovery Technologies Propel Demand for Comprehensive Surgical Ecosystems
  • Surge in Brain Tumor and Epilepsy Resections Drives Procedure-Specific Tool Demand
  • Rising Investment in Neurovascular Surgery Supports Treatment of Aneurysms and AVMs
  • Expansion of Hospital Neuroscience Programs Enhances Institutional Capacity and Case Load
  • Heightened Awareness of Neurosurgical Advancements Spurs Patient Willingness for Early Treatment
  • Variability in Neurosurgical Reimbursement Structures Creates Regional Access Inequities
  • Advancements in Neuro-monitoring Tools Support Real-Time Intraoperative Decision-Making
  • Global Initiatives for Stroke and Neurotrauma Management Reinforce Surgical Infrastructure Development
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Neurosurgery Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Neurosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Neurosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Neurosurgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Neuro Interventional Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Neuro Interventional Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Neuro Interventional Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Neuroendoscopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Neuroendoscopes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Neuroendoscopes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Neurosurgical Drills by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Neurosurgical Drills by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Neurosurgical Drills by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Radiosurgery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Radiosurgery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Radiosurgery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Dura Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Dura Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Dura Substitutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Craniofacial Trauma Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Craniofacial Trauma Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Craniofacial Trauma Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Brain Cancer Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Brain Cancer Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Brain Cancer Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Spine & Skull Base Tumors Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Spine & Skull Base Tumors Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Spine & Skull Base Tumors Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Traumatic Brain Injuries Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Traumatic Brain Injuries Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Traumatic Brain Injuries Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Hospitals & Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Hospitals & Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Hospitals & Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 47: USA Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• JAPAN
  • Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• CHINA
  • Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 74: China Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• EUROPE
  • Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Neurosurgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Neurosurgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Neurosurgery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• FRANCE
  • Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 95: France Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 101: France Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• GERMANY
  • Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Germany 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 110: Germany Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Germany Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Germany 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Italy 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 119: Italy Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Italy Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Italy 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 122: UK Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: UK 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 128: UK Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: UK Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: UK 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Spain 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 137: Spain Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Spain Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Spain 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Russia 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 146: Russia Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Russia Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Russia 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Rest of Europe Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Rest of Europe 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Neurosurgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Neurosurgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Neurosurgery by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Asia-Pacific Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Asia-Pacific 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Australia 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 176: Australia Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Australia Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Australia 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• INDIA
  • Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 179: India Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: India 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 185: India Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: India Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: India 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: South Korea 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 194: South Korea Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: South Korea Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: South Korea 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Asia-Pacific Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Rest of Asia-Pacific 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Neurosurgery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Neurosurgery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Neurosurgery by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Latin America 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 215: Latin America Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Latin America Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Latin America 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Argentina 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 224: Argentina Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Argentina Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Argentina 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Brazil 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 233: Brazil Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Brazil Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Brazil 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Mexico 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 242: Mexico Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Mexico Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Mexico 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Latin America Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Latin America 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Neurosurgery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Neurosurgery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Neurosurgery by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Middle East 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 263: Middle East Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Middle East Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Middle East 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Iran 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 272: Iran Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Iran Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Iran 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Israel 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 281: Israel Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Israel Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Israel 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Saudi Arabia Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Saudi Arabia 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: UAE 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 299: UAE Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: UAE Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: UAE 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Middle East Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Middle East 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• AFRICA
  • Neurosurgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Neurosurgery by Product Type - Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Neurosurgery by Product Type - Percentage Breakdown of Value Sales for Neuro Interventional Devices, Neuroendoscopes, Neurosurgical Drills, Radiosurgery Systems, Dura Substitutes and Other Product Types for the Years 2015, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Neurosurgery by Indication - Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Africa 15-Year Perspective for Neurosurgery by Indication - Percentage Breakdown of Value Sales for Craniofacial Trauma Indication, Other Indications, Brain Cancer Indication, Spine & Skull Base Tumors Indication and Traumatic Brain Injuries Indication for the Years 2015, 2025 & 2030
  • TABLE 317: Africa Recent Past, Current & Future Analysis for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Africa Historic Review for Neurosurgery by End-Use - Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Africa 15-Year Perspective for Neurosurgery by End-Use - Percentage Breakdown of Value Sales for Hospitals & Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION